About Us

Speed and cost improvements in gene sequencing are now outpacing Moore’s Law.

Breakthrough therapies are harnessing the body’s own immune system to defeat cancer.

Digital health technologies are empowering patients and streamlining care.

Novel medical devices are improving outcomes and hastening surgical recovery.

We invest globally in companies that promote health, increase longevity, and alleviate human suffering. Our interests range from novel biotechnology for neglected pediatric diseases to affordable models of senior care. We align with strong secular trends, energetic management, outstanding science, and responsible corporate citizenship. Together, these success factors reliably grow stakeholder value over time — just as brooks on a mountain converge into growing bodies of water.


Our team combines decades of cross-disciplinary experience in medicine, basic science, investing, finance, and operations.

Nikej Shah, MD

Managing Partner

Dr. Shah oversees investment strategy and portfolio management.

David E. Thomas

Chief Operating Officer

Mr. Thomas oversees operations, finance, human resources, and compliance.

Contact Us

New York:

630 Fifth Avenue, Suite 2000
New York, NY 10111
United States